Mark E. Hammer

1.8k total citations
28 papers, 1.1k citations indexed

About

Mark E. Hammer is a scholar working on Ophthalmology, Radiology, Nuclear Medicine and Imaging and Neurology. According to data from OpenAlex, Mark E. Hammer has authored 28 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Ophthalmology, 19 papers in Radiology, Nuclear Medicine and Imaging and 5 papers in Neurology. Recurrent topics in Mark E. Hammer's work include Intraocular Surgery and Lenses (13 papers), Retinal and Macular Surgery (12 papers) and Retinal Diseases and Treatments (6 papers). Mark E. Hammer is often cited by papers focused on Intraocular Surgery and Lenses (13 papers), Retinal and Macular Surgery (12 papers) and Retinal Diseases and Treatments (6 papers). Mark E. Hammer collaborates with scholars based in United States, Germany and Switzerland. Mark E. Hammer's co-authors include W. Sanderson Grizzard, George F. Hilton, Douglas Taren, Iván J. Suñer, Marc C. Peden, Daniel A. Brinton, Kirk H. Packo, Steven R. Leff, Timothy P. Flood and Craig M. Morgan and has published in prestigious journals such as Ophthalmology, American Journal of Ophthalmology and SAE technical papers on CD-ROM/SAE technical paper series.

In The Last Decade

Mark E. Hammer

24 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark E. Hammer United States 17 969 814 209 104 83 28 1.1k
David R. Chow Canada 17 721 0.7× 542 0.7× 122 0.6× 106 1.0× 30 0.4× 53 821
Morton S. Cox United States 18 1.2k 1.3× 1.1k 1.4× 252 1.2× 51 0.5× 65 0.8× 25 1.3k
Riaz Asaria United Kingdom 14 975 1.0× 785 1.0× 173 0.8× 60 0.6× 15 0.2× 25 1.1k
Fatemeh Bazvand Iran 14 462 0.5× 389 0.5× 51 0.2× 37 0.4× 60 0.7× 79 637
A J Luff United Kingdom 14 484 0.5× 295 0.4× 64 0.3× 166 1.6× 13 0.2× 37 702
Brian C. Joondeph United States 20 1.1k 1.1× 618 0.8× 112 0.5× 57 0.5× 37 0.4× 55 1.3k
Louisa Wickham United Kingdom 19 1.0k 1.1× 916 1.1× 269 1.3× 62 0.6× 13 0.2× 51 1.1k
Isaac Boniuk United States 14 774 0.8× 626 0.8× 213 1.0× 102 1.0× 6 0.1× 30 827
Carlos Mateo Spain 22 1.2k 1.2× 936 1.1× 215 1.0× 40 0.4× 23 0.3× 75 1.3k
Hugh Beckman United States 15 549 0.6× 386 0.5× 49 0.2× 51 0.5× 14 0.2× 27 777

Countries citing papers authored by Mark E. Hammer

Since Specialization
Citations

This map shows the geographic impact of Mark E. Hammer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark E. Hammer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark E. Hammer more than expected).

Fields of papers citing papers by Mark E. Hammer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark E. Hammer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark E. Hammer. The network helps show where Mark E. Hammer may publish in the future.

Co-authorship network of co-authors of Mark E. Hammer

This figure shows the co-authorship network connecting the top 25 collaborators of Mark E. Hammer. A scholar is included among the top collaborators of Mark E. Hammer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark E. Hammer. Mark E. Hammer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Peden, Marc C., Mark E. Hammer, & Iván J. Suñer. (2018). DILUTE POVIDONE-IODINE PROPHYLAXIS MAINTAINS SAFETY WHILE IMPROVING PATIENT COMFORT AFTER INTRAVITREAL INJECTIONS. Retina. 39(11). 2219–2224. 19 indexed citations
2.
Peden, Marc C., Iván J. Suñer, Mark E. Hammer, & W. Sanderson Grizzard. (2015). Long-Term Outcomes in Eyes Receiving Fixed-Interval Dosing of Anti–Vascular Endothelial Growth Factor Agents for Wet Age-Related Macular Degeneration. Ophthalmology. 122(4). 803–808. 109 indexed citations
4.
Hammer, Mark E.. (2012). Retinal vessel analysis and oximetry ‐ technical advances and clinical applications. Acta Ophthalmologica. 90(s249). 0–0. 1 indexed citations
5.
Gehlert, Sebastian, Jens Dawczynski, Mark E. Hammer, & J. Strobel. (2010). Nichtinvasive Messung der Sauerstoffsättigung retinaler Gefäße bei retinalen Astarterienverschlüssen unter Therapie. Klinische Monatsblätter für Augenheilkunde. 227(12). 976–980. 6 indexed citations
6.
Hammer, Mark E., et al.. (2009). Analysis of Fiber-Reinforced Plastic Tanks by Capturing Anisotropic Material Properties. SAE technical papers on CD-ROM/SAE technical paper series. 1.
7.
Hammer, Mark E. & W. Sanderson Grizzard. (2003). ENDOSCOPY FOR EVALUATION AND TREATMENT OF THE CILIARY BODY IN HYPOTONY. Retina. 23(1). 30–36. 22 indexed citations
8.
Steinmetz, Robert L., W. Sanderson Grizzard, & Mark E. Hammer. (2002). Vitrectomy for diabetic traction retinal detachment using the multiport illumination system. Ophthalmology. 109(12). 2303–2307. 22 indexed citations
9.
Hammer, Mark E. & Curtis E. Margo. (2002). Unilateral Multifocal Uveal Melanoma With Occult Ring Melanoma. Archives of Ophthalmology. 120(8). 1090–1090. 3 indexed citations
10.
Wisniewski, Stephen R., Mark E. Hammer, W. Sanderson Grizzard, et al.. (1997). An Investigation of the Hospital Charges Related to the Treatment of Endophthalmitis in the Endophthalmitis Vitrectomy Study. Ophthalmology. 104(5). 739–745. 16 indexed citations
11.
Hammer, Mark E., Curtis E. Margo, & W. Sanderson Grizzard. (1997). Complex Retinal Detachment Treated With Silicone Oil or Sulfur Hexafluoride Gas: A Randomized Clinical Trial. Ophthalmic surgery, lasers & imaging retina. 28(11). 926–931. 15 indexed citations
12.
Grizzard, W. Sanderson, George F. Hilton, Mark E. Hammer, Douglas Taren, & Daniel A. Brinton. (1995). Pneumatic Retinopexy Failures. Ophthalmology. 102(6). 929–936. 40 indexed citations
13.
Cohen, Steven M., Harry W. Flynn, Timothy G. Murray, et al.. (1995). Endophthalmitis after Pars Plana Vitrectomy. Ophthalmology. 102(5). 705–712. 111 indexed citations
14.
Hammer, Mark E., et al.. (1995). THRESHOLD RETINOPATHY OF PREMATURITY. Retina. 15(6). 486–489. 11 indexed citations
15.
Hammer, Mark E., et al.. (1995). Threshold retinopathy of prematurity. Transition from cryopexy to laser treatment.. PubMed. 15(6). 486–9. 18 indexed citations
16.
Grizzard, W. Sanderson, George F. Hilton, Mark E. Hammer, & Douglas Taren. (1994). A multivariate analysis of anatomic success of retinal detachments treated with scleral buckling. Graefe s Archive for Clinical and Experimental Ophthalmology. 232(1). 1–7. 94 indexed citations
17.
Grizzard, W. Sanderson, et al.. (1991). Perforating Ocular Injuries Caused by Anesthesia Personnel. Ophthalmology. 98(7). 1011–1016. 112 indexed citations
18.
Hilton, George F., Paul E. Tornambe, Daniel A. Brinton, et al.. (1990). The complication of pneumatic retinopexy.. PubMed. 88. 191–207; discussion 207. 18 indexed citations
19.
Wu, Wenbin, W. H. Peters, & Mark E. Hammer. (1987). Basic Mechanical Properties of Retina in Simple Elongation. Journal of Biomechanical Engineering. 109(1). 65–67. 47 indexed citations
20.
Hammer, Mark E., et al.. (1984). Viscous corneal protection by sodium hyaluronate, chondroitin sulfate, and methylcellulose.. PubMed. 25(11). 1329–32. 47 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026